Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases

• Published in: International journal of clinical oncology Vol. 27; no. 2; pp. 301 - 309
• Main Authors: Ono, Masanori, Matsumoto, Kimikazu, Boku, Narikazu, Fujii, Nobuharu, Tsuchida, Yumi, Furui, Tatsuro, Harada, Miyuki, Kanda, Yoshinobu, Kawai, Akira, Miyachi, Mitsuru, Murashima, Atsuko, Nakayama, Robert, Nishiyama, Hiroyuki, Shimizu, Chikako, Sugiyama, Kazuhiko, Takai, Yasushi, Fujio, Keishi, Morishige, Ken-Ichirou, Osuga, Yutaka, Suzuki, Nao
• Format: Journal Article
• Language: English
• Published: Singapore Springer Singapore 01.02.2022; Springer Nature B.V
• Subjects: Adolescent; Cancer; Cancer Research; Child; Classification; Fertility; Fertility Preservation; Humans; Invited Review; Invited Review Article; Japan; Medical Oncology; Medicine; Medicine & Public Health; Neoplasms - drug therapy; Oncology; Patients; Pediatrics; Preservation; Surgical Oncology; Toxicity; Young Adult; Young adults; Japan; Cyclophosphamide; Japan Society for Fertility Preservation; Japan Society of Clinical Oncology; Fertility preservation; Oncofertility; Pediatric, adolescent, and young adults with cancer

In recent years, local governments in Japan have established a public financial support system for fertility preservation in pediatric, adolescent, and young adult cancer patients. Fertility preservation has become popular for patients with cancers included in the gonadal toxicity risk classificatio...